This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Maar Dora Francesco Carelli, University of Milan (12 Dec 2019)
Anastrozole reduces breast cancer rates for ... Queen Mary University of London-led research finds Anastrozole ... (10 Dec 2019)
Taking fish oil tablets for four weeks ... Fish oil supplements can significantly improve ‘night vision’, ... (12 Dec 2019)
Give a Gift this Christmas which gives back The story of medicine is the story of civilization, from an ... (12 Dec 2019)
Elderly people should aim to keep up step ... Just two weeks of inactivity increases body fat and harms ... (12 Dec 2019)
Wednesday, 18 October 2017 06:47

The cardiovascular risk of antidepressant drugs: New data. Featured

Rate this item
(0 votes)

In the current issue of Psychotherapy and Psychosomatics a meta-analysis is performed on the cardiovascular risk of antidepressant drugs.Antidepressants are commonly prescribed medications, but their long-term health effects are debated. Antidepressants disrupt multiple adaptive processes regulated by evolutionarily ancient biochemicals, potentially increasing mortality. However, many antidepressants also have anticlotting properties that can be efficacious in treating cardiovascular disease.


Authors conducted a meta-analysis assessing the effects of antidepressants on all-cause mortality and cardiovascular events in general-population and cardiovascular-patient samples. Two reviewers independently assessed articles from PubMed, EMBASE, and Google Scholar for antidepressant-related mortality controlling for depression and other comorbidities. From these articles, information was extracted about cardiovascular events, cardiovascular risk status, and antidepressants class. Authors conducted mixed-effect meta-analyses testing sample type and antidepressants class as moderators of all-cause mortality and new cardiovascular events. Seventeen studies met the search criteria.


Results showed that in the general-population, antidepressants use increased the risks of mortality and new cardiovascular events. In cardiovascular patients, antidepressants use did not significantly affect risks. Antidepressants class also moderated mortality, but the serotonin reuptake inhibitors were not significantly different from tricyclic antidepressants. Only “other antidepressants” were differentiable from tricyclic antidepressants. Mortality risk estimates increased when we analyzed the subset of studies controlling for premedication depression, suggesting the absence of confounding by indication.

Authors concluded that the results support the hypothesis that antidepressants are harmful in the general population but less harmful in cardiovascular patients.


 


Source: Journal of Psychotherapy and Psychosomatics

Full bibliographic information:
The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis. Psychother Psychosom 2017;86:268-28

 

Read 2326 times Last modified on Wednesday, 18 October 2017 08:09

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…